Nona Biosciences
Nona Biosciences is a global biotechnology company specializing in fully human, AI-enhanced antibody discovery platforms for next-generation therapeutic formats. The company offers integrated services from target validation and antibody discovery through preclinical research, leveraging proprietary Harbour Mice® transgenic mouse platforms that produce fully human monoclonal antibodies in both traditional (H2L2) and heavy chain-only (HCAb) formats. Their business model includes partnerships with academic institutions, startups, and biopharmaceutical companies, providing flexible collaboration models and total solutions from "Idea to IND". With over 100 partners, 300+ projects, and 19+ IND/clinical stage therapies, Nona Biosciences is positioned as a trusted drug discovery partner driving transformative biotherapeutic innovation globally.
Nona Biosciences
Nona Biosciences is a global biotechnology company specializing in fully human, AI-enhanced antibody discovery platforms for next-generation therapeutic formats. The company offers integrated services from target validation and antibody discovery through preclinical research, leveraging proprietary Harbour Mice® transgenic mouse platforms that produce fully human monoclonal antibodies in both traditional (H2L2) and heavy chain-only (HCAb) formats. Their business model includes partnerships with academic institutions, startups, and biopharmaceutical companies, providing flexible collaboration models and total solutions from "Idea to IND". With over 100 partners, 300+ projects, and 19+ IND/clinical stage therapies, Nona Biosciences is positioned as a trusted drug discovery partner driving transformative biotherapeutic innovation globally.